Clinical Trial Update: Improving Retreatment Success (IMPRESS) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update for IMPRESS exploring retreatment strategies for recurrent tuberculosis; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Snippet

Sponsor: Centre for the AIDS Programme of Research in South Africa | Conditions: Recurrent Tuberculosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-08-05